Reading Room Production — page 358
of 496 pages
← p.357 p.359 → · this page in the original PDF · package
you have a better understanding of what Francis has in
iks
From: "Hudson, Kathy (NIH/OD) [E]"
@nih.gov>
To: "Ranganathan, Rajesh (NIH/OD) [C]"
@nih.gov>
Cc: "Tabak, Lawrence (NIH/OD) [E]"
@nih.gov>
Subject: RE: Discussion about Cures Acceleration Network and the President's Medical
Countermeasures Initiative (MCMI)
Date: Thu, 18 Nov 2010 21:14:33 -0500
Importance: Normal
Thanks for asking. My knee jerk reaction is to support your misgivings. I think it is a bad idea for a whole bunch of
reasons. JJ erred in pointing you to the white house. Protocol dictates that we don't talk to the white house without going
through hhs. It would be okay to yak with one of our detailees but this has taken a turn. Plus, I suspect you know next to
nothing about biosecurity and BARDA. This is not really your domain and frankly, not a central issue to NCTS at the
outset. It IS the domain of other NIH staff who would probably be a little miffed about why you are suddenly in the middle
of their "space." NIAID has programs in this arena and you should learn about them but they ain't coming into to ncts at the
get go and the politics around biosecurity is complex.
I would suggest to Richard that the meeting be "delayed" until you have a better understanding of what Francis has in
mind, yadda yadda.
-----Original Message-----
From: Ranganathan, Rajesh (NIH/OD) [C]
Sent: Thursday, November 18, 2010 6:51 PM
To: Hudson, Kathy (NIH/OD) [E]
Cc: Tabak, Lawrence (NIH/OD) [E]
Subject: FW: Discussion about Cures Acceleration Network and the President's Medical Countermeasures Initiative
(MCMI)
Kathy:
Some background for you (I was able to tell Larry in person)..Tony sent me
to JJ McGowan, who thought that Richard Hatchett, currently on detail to the
White House is someone I should talk to because he might have the skill set
to help with NCTS. I checked in with Larry and we agreed that I should
certainly meet such people and hear them out. So, when Richard reached out,
I agreed to go down to the EEOB to meet him. He appears to have mentioned
that he is meeting me to Ms. Heidi Avery (Deputy Homeland Security Adviser
to the President), who now wants to join in and the meeting got moved to
Monday to accommodate her schedule. Please see below for what Richard thinks
Ms. Avery wants to know.
Two issues: a) there is not much I can say about CAN or anything else re:
NCTS on Monday, and b) as a contractor, I should not be reprenseting the NIH
externally. Larry has arranged from Robin from DPCPSI to go with me to
ensure that the NIH is represented by an employee.
But I am wondering if this meeting with Ms. Avery should even happen - feels
too early in the process Please advise on the ramifications of
cancelling/postponing on her vs. taking the meeting and not saying anything
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/reading_room/358